Document
IPR2015-01980, No. 1023 Exhibit - AMNEAL 1023 Haines et al, Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity The multiple sclerosis genetics group (P.T.A.B. S...
Cite Document
IPR2015-01980, No. 1023 Exhibit - AMNEAL 1023 Haines et al, Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity The multiple sclerosis genetics group (P.T.A.B. Sep. 25, 20
+ More Snippets
Document
IPR2015-01980, No. 1022 Exhibit - AMNEAL 1022 E Lobel, et al, Copolymer 1, 21 2 DRUGS OF THE FUTURE (P.T.A.B. Sep. 25, 2015)
Cite Document
IPR2015-01980, No. 1022 Exhibit - AMNEAL 1022 E Lobel, et al, Copolymer 1, 21 2 DRUGS OF THE FUTURE (P.T.A.B. Sep. 25, 2015)
+ More Snippets
Document
IPR2015-01980, No. 1050 Exhibit - AMNEAL 1050 Avonex Product Label 2006 (P.T.A.B. Sep. 25, 2015)
Cite Document
IPR2015-01980, No. 1050 Exhibit - AMNEAL 1050 Avonex Product Label 2006 (P.T.A.B. Sep. 25, 2015)
+ More Snippets
Document
IPR2015-01980, No. 1048 Exhibit - AMNEAL 1048 Betaseron US Product Label 2003 (P.T.A.B. Sep. 25, 2015)
Cite Document
IPR2015-01980, No. 1048 Exhibit - AMNEAL 1048 Betaseron US Product Label 2003 (P.T.A.B. Sep. 25, 2015)
+ More Snippets
Document
IPR2015-01980, No. 1008 Exhibit - AMNEAL 1008 Shlomo Flechter et al, Copolymer 1 Glatiramer Acetate in Relapsing Forms of Multiple Sclerosis (P.T.A.B. Sep. 25, 2015)
Cite Document
IPR2015-01980, No. 1008 Exhibit - AMNEAL 1008 Shlomo Flechter et al, Copolymer 1 Glatiramer Acetate in Relapsing Forms of Multiple Sclerosis (P.T.A.B. Sep. 25, 2015)
+ More Snippets
Document
IPR2015-01980, No. 1057 Exhibit - AMNEAL 1057 Concepts in clinical pharmacokinetics, in INTRODUCTION TO PHARMACOKINETICS AND PHARMACODYNAMICS (P.T.A.B. Sep. 25, 2015)
Cite Document
IPR2015-01980, No. 1057 Exhibit - AMNEAL 1057 Concepts in clinical pharmacokinetics, in INTRODUCTION TO PHARMACOKINETICS AND PHARMACODYNAMICS (P.T.A.B. Sep. 25, 2015)
+ More Snippets
Document
IPR2015-01980, No. 1019 Exhibit - AMNEAL 1019 Affidavit of Marlene S Bobka dated January 5, 2015 and 1996 FDA Meeting Agenda minutes from the Peripheral and Central Nervous System D...
Cite Document
IPR2015-01980, No. 1019 Exhibit - AMNEAL 1019 Affidavit of Marlene S Bobka dated January 5, 2015 and 1996 FDA Meeting Agenda minutes from the Peripheral and Central Nervous System Drug Advisory Commit
+ More Snippets
Document
IPR2015-01980, No. 1036 Exhibit - AMNEAL 1036 James Rasmussen International Patent Publication No WO 2005120542 A2 (P.T.A.B. Sep. 25, 2015)
Cite Document
IPR2015-01980, No. 1036 Exhibit - AMNEAL 1036 James Rasmussen International Patent Publication No WO 2005120542 A2 (P.T.A.B. Sep. 25, 2015)
+ More Snippets
Document
IPR2015-01980, No. 1042 Exhibit - AMNEAL 1042 Soares et al, Localized panniculitis secondary to subcutaneous glatiramer acetate injections for the treatment of multiple sclerosis (P.T.A.B. Se...
Cite Document
IPR2015-01980, No. 1042 Exhibit - AMNEAL 1042 Soares et al, Localized panniculitis secondary to subcutaneous glatiramer acetate injections for the treatment of multiple sclerosis (P.T.A.B. Sep. 25, 20
+ More Snippets
Document
IPR2015-01980, No. 1012 Exhibit - AMNEAL 1012 Shlomo Flechter et al, Comparison of glatiramer acetate Copaxone and interferon Betaferon in multiple sclerosis patients an open label 2 year ...
Cite Document
IPR2015-01980, No. 1012 Exhibit - AMNEAL 1012 Shlomo Flechter et al, Comparison of glatiramer acetate Copaxone and interferon Betaferon in multiple sclerosis patients an open label 2 year follow up (P
+ More Snippets
Document
IPR2015-01980, No. 1003 Exhibit - AMNEAL 1003 Declaration of, and Curriculum Vitae of, and Materials Reviewed by Stephen J Peroutka, MD, PhD (P.T.A.B. Sep. 25, 2015)
Cite Document
IPR2015-01980, No. 1003 Exhibit - AMNEAL 1003 Declaration of, and Curriculum Vitae of, and Materials Reviewed by Stephen J Peroutka, MD, PhD (P.T.A.B. Sep. 25, 2015)
+ More Snippets
Document
IPR2015-01980, No. 1026 Exhibit - AMNEAL 1026 Giancarlo Comi et al, European Canadian multicenter, double blind, randomized, placebo controlled study of the effects of glatiramer acetate o...
Cite Document
IPR2015-01980, No. 1026 Exhibit - AMNEAL 1026 Giancarlo Comi et al, European Canadian multicenter, double blind, randomized, placebo controlled study of the effects of glatiramer acetate on magnetic r
+ More Snippets
Document
IPR2015-01980, No. 1017 Exhibit - AMNEAL 1017 FDA, GUIDELINE FOR INDUSTRY Dose Response Information to Support Drug Registration (P.T.A.B. Sep. 25, 2015)
Cite Document
IPR2015-01980, No. 1017 Exhibit - AMNEAL 1017 FDA, GUIDELINE FOR INDUSTRY Dose Response Information to Support Drug Registration (P.T.A.B. Sep. 25, 2015)
+ More Snippets
Document
IPR2015-01980, No. 1035 Exhibit - AMNEAL 1035 Michael Franklin et al, Drug Absorption, Action, and Disposition, in REMINGTON (P.T.A.B. Sep. 25, 2015)
Cite Document
IPR2015-01980, No. 1035 Exhibit - AMNEAL 1035 Michael Franklin et al, Drug Absorption, Action, and Disposition, in REMINGTON (P.T.A.B. Sep. 25, 2015)
+ More Snippets
Document
IPR2015-01980, No. 1047 Exhibit - AMNEAL 1047 Copaxone US Product Label 2001 (P.T.A.B. Sep. 25, 2015)
Cite Document
IPR2015-01980, No. 1047 Exhibit - AMNEAL 1047 Copaxone US Product Label 2001 (P.T.A.B. Sep. 25, 2015)
+ More Snippets